Gliosarcoma
📧 Sign up to get email alerts when something new happens for Gliosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Update: Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma [Phase 3]
Phase 3 trial update evaluating adding lomustine to standard temozolomide and radiation for newly diagnosed MGMT-methylated glioblastoma; st…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 2]
A Phase 2 clinical trial update exploring whether peripheral blood immunologic biomarkers predict response to adjuvant immune checkpoint inh…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [Phase 1]
Phase 1 clinical trial update exploring vorinostat with temozolomide for malignant gliomas in adults, with active-not-recruiting status acro…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma [Phase 1]
Phase 1 trial evaluating ABBV-637 or ABBV-155 in combination with ERAS-801 for glioblastoma and gliosarcoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma [Phase 2]
Phase 2 clinical trial assessing pembrolizumab with standard therapy for glioblastoma and gliosarcoma; status update indicates ongoing or co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) [Phase 1]
Phase 1 study evaluating re-administration of C134 in patients with recurrent glioblastoma and related brain gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]
Phase 1 dose-escalation trial of re-irradiation in good-prognosis recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) [Phase 1]
A Phase I pilot study evaluating S-Gboxin in combination with standard glioblastoma therapy; the trial assessing anti-glioblastoma effects i…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer [Phase 1]
A Phase 1 clinical trial of AMG 232 (KRT-232) in patients with brain cancers including glioblastoma and gliosarcoma was terminated; the stud…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating atezolizumab in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma has…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma [EARLY_Phase 1]
Early-phase study evaluating the use of 18F-FDOPA PET imaging to plan surgery and radiation therapy for adults with newly diagnosed malignan…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma [Phase 2]
A Phase 2 trial evaluating spectroscopic MRI-guided radiation therapy planning for glioblastoma and gliosarcoma has completed with results p…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Trial of C134 in Patients With Recurrent GBM [Phase 1]
Phase 1 clinical trial update for C134 in recurrent glioblastoma and related brain cancers reports results with results posted on 2025-07-03…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma [Phase 1]
Phase 1 clinical trial evaluating mycophenolate mofetil in combination with radiation therapy for glioblastoma and related astrocytomas; the…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma [Phase 1]
Phase 1 trial evaluating tinostamustine with or without radiation therapy in newly diagnosed MGMT-unmethylated glioblastoma; the study has c…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating NovoTTF-100A (tumor treating fields) combined with bevacizumab in recurrent glioblastoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma [Phase 1]
A Phase 1 trial combining partial brain radiotherapy, temozolomide, chloroquine, and tumor treating fields for newly diagnosed glioblastoma …
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma [Phase 1]
A Phase 1 trial evaluating Lapatinib Ditosylate before surgical resection in adults with recurrent high-grade glioma has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma [Phase 1]
Phase 1 trial evaluating selinexor in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma (and gliosarcoma)…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
This Phase 2 trial evaluating bevacizumab with temozolomide in older patients with newly diagnosed glioblastoma or gliosarcoma has completed…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma [Phase 2]
A Phase 2 clinical trial assessing the addition of plerixafor to standard temozolomide-based chemoradiotherapy for glioblastoma has complete…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma [Phase 2, Phase 3]
This update reports the results of a randomized Phase 2/3 trial comparing ipilimumab and nivolumab with radiation therapy versus the standar…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]
Phase 1 clinical trial update evaluating safety and preliminary efficacy of carboxylesterase-expressing allogeneic neural stem cells in comb…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children [Phase 1]
Phase 1b trial update for PVSRIPO in recurrent malignant glioma in children has completed enrollment and results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG [Phase 2]
A Phase 2 study of the MEK inhibitor binimetinib plus the BRAF inhibitor encorafenib in adults with recurrent BRAF V600-mutant high-grade gl…